颅咽管瘤IFN-α囊内化学治疗的现状

Current status of intracystic chemotherapy with IFN-αfor craniopharyngioma

颅咽管瘤(CP)是一种儿童常见的颅脑良性肿瘤。囊内注射药物进行化学治疗是有效的治疗方式,包括放射性同位素、博来霉素以及干扰素(IFN)-α。IFN治疗后的CP患者,相较于传统的药物毒性产生的不良反应更轻微且多是可控的,但进行IFN治疗之前应进行渗漏检查。近十年研究证据表明,IFN-α治疗肿瘤控制程度好,不良反应小,是目前可靠的一种治疗选择,由于在国内缺乏足够的临床证据而未得到广泛的应用,但因其轻微的不良反应,同时能够保证较好的治疗效果,使得其成为替代传统囊内化学治疗药物最有潜力的选择。

Craniopharyngioma(CP)is a common benign brain tumor in children.Intracapsular injection of drugs for chemotherapy is an effective treatment,including radioisotopes,bleomycin and interferon(IFN)-α.Compared with traditional drugs,the adverse reactions of CP patients after IFN treatment are mild and mostly controllable,and leakage examination should be carried out before IFN treatment.According to the research evidence in the past decade,IFN-αis a reliable treatment option with good tumor control and less adverse reactions.It has not been widely used due to the lack of sufficient clinical evidence in China.However,because of its mild adverse reactions and good therapeutic effect,it has become the most potential alternative to traditional intracapsular chemotherapy.